PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAllograft
Allograft
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1501 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Kidney transplantationD016030——1434183476168
LeukemiaD007938—C95458420325155
Myeloid leukemia acuteD015470—C92.028441732098
Myeloid leukemiaD007951—C9225451421588
Graft rejectionD006084——5157104478
Intervertebral disc degenerationD055959HP_0008419—12226369
Renal insufficiencyD051437HP_0000083N199108103265
SyndromeD013577——1332421258
Vascular diseasesD014652EFO_0004264I7714562642
UlcerD014456MPATH_579—14—53342
Show 92 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190—D4630537—1696
LymphomaD008223—C85.919584—1685
PreleukemiaD011289——20376—964
Hematologic neoplasmsD019337——22314—1462
Precursor cell lymphoblastic leukemia-lymphomaD054198——20306—1159
Multiple myelomaD009101—C90.016371—1259
NeoplasmsD009369—C8017283—1047
Non-hodgkin lymphomaD008228—C85.911301—841
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—10225—941
Plasma cell neoplasmsD054219——10271—538
Show 48 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hodgkin diseaseD006689—C81922——933
B-cell chronic lymphocytic leukemiaD015451—C91.1719——526
Hematologic diseasesD006402EFO_0005803D75.914——813
T-cell lymphomaD016399——19——312
AtrophyD001284——11——1012
Mantle-cell lymphomaD020522——18——311
PlasmacytomaD010954—C90.338——111
B-cell lymphomaD016393——37——110
Congenital abnormalitiesD000013EFO_0003915Q89.932——59
Large b-cell lymphoma diffuseD016403—C83.326——29
Show 142 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tooth extractionD014081——1———1213
Low back painD017116HP_0003419M54.51———78
Back painD001416HP_0003418M541———78
ArthritisD001168HP_0001369M05-M141———78
Bone transplantationD016025——1———34
ObesityD009765EFO_0001073E66.91———23
Neurogenic urinary bladderD001750HP_0000011N311———23
Lung diseasesD008171HP_0002088J98.41———23
Heart failureD006333HP_0001635I501———23
MelanomaD008545——1———12
Show 23 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PeriodontitisD010518EFO_0000649K05.3————1111
Intervertebral disc displacementD007405EFO_1001800—————99
Spinal cord diseasesD013118HP_0002196G95.9————88
RadiculopathyD011843—M54.1————88
Heart diseasesD006331EFO_0003777I51.9————88
Tissue preservationD014021——————77
Dental implantsD015921——————77
Spinal fusionD013123——————66
Congenital heart defectsD006330HP_0001627Q24.9————66
Joint dislocationsD004204HP_0001373—————55
Show 223 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use